Epidermal Hyperplasia and Elevated HB-EGF are More Prominent in Retinoid Dermatitis Compared with Irritant Contact Dermatitis Induced by Benzalkonium Chloride.

Jung Eun Lee, Jae Yong Chang, Sang Eun Lee, Moon Young Kim, Jeong Seon Lee, Min Geol Lee, Soo-Chan Kim
Author Information
  1. Jung Eun Lee: Department of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND: 'Retinoid dermatitis' is a retinoid-induced irritant contact dermatitis (ICD). The mechanism of retinoid dermatitis may be different from that of other ICDs. However, it remains uncertain how topical retinoid induce ICD.
OBJECTIVE: We compared several aspects of contact dermatitis induced by topical retinol and benzalkonium chloride (BKC) on hairless mice skin.
METHODS: 2% retinol or 2.5% BKC was applied to hairless mice and transepidermal water loss (TEWL), ear thickness, histologic and immunohistochemical findings were compared. We also compared mRNA expression of inflammatory cytokines, epidermal differential markers, cyclooxygenases (COXs) and heparin binding epidermal growth factor like growth factor (HB-EGF).
RESULTS: Topical application of 2% retinol and 2.5% BKC increased TEWL and ear thickness in similar intensity. Epidermal hyperplasia was more prominent in retinol treated skin. Proliferating cell nuclear antigen, involucrin and loricrin expression were higher in retinol-treated skin than in BKC-treated skin. Filaggrin, however, was more expressed in BKC-treated skin. The mRNA expression of IL-8, TNF-alpha, COX-2, involucrin, loricrin and filaggrin were increased in both retinol- and BKC-treated skin in similar intensity. HB-EGF was more significantly increased in retinol-treated skin.
CONCLUSION: Elevated HB-EGF and epidermal hyperplasia are more prominent features of retinoid dermatitis than in BKC-induced ICD.

Keywords

References

  1. Arch Dermatol Res. 1996 Sep;288(10):615-20 [PMID: 8919045]
  2. J Invest Dermatol. 1995 May;104(5):779-83 [PMID: 7738355]
  3. Mol Cell Biol. 1989 Nov;9(11):4846-51 [PMID: 2574824]
  4. J Invest Dermatol. 2004 Dec;123(6):1078-85 [PMID: 15610518]
  5. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1398-402 [PMID: 1741395]
  6. FASEB J. 1996 Jul;10(9):1002-13 [PMID: 8801161]
  7. Biochim Biophys Acta. 1996 Jan 5;1299(1):125-40 [PMID: 8555245]
  8. J Invest Dermatol. 1992 Sep;99(3):283-8 [PMID: 1355099]
  9. Br J Dermatol. 1990 Oct;123(4):457-66 [PMID: 2095177]
  10. J Biol Chem. 1996 Dec 27;271(52):33157-60 [PMID: 8969167]
  11. Exp Dermatol. 1998 Dec;7(6):391-7 [PMID: 9858142]
  12. Differentiation. 1992 Jan;49(1):39-46 [PMID: 1378029]
  13. Differentiation. 1990 Dec;45(3):221-9 [PMID: 2090523]
  14. Exp Dermatol. 2003;12 Suppl 2:28-34 [PMID: 14756521]
  15. J Invest Dermatol. 1995 Jun;104(6):902-9 [PMID: 7769256]
  16. J Biol Chem. 1996 Oct 25;271(43):26954-61 [PMID: 8900181]
  17. Contact Dermatitis. 1975 Oct;1(5):273-6 [PMID: 1235276]
  18. J Invest Dermatol. 2006 Apr;126(4):732-9 [PMID: 16470170]
  19. Cancer Lett. 2000 Dec 20;161(2):177-83 [PMID: 11090967]
  20. EMBO J. 1999 Mar 15;18(6):1539-48 [PMID: 10075925]
  21. J Invest Dermatol. 1992 Mar;98(3):343-50 [PMID: 1372028]
  22. Arch Dermatol Res. 1996 Oct;288(11):684-90 [PMID: 8931871]
  23. Toxicol Lett. 2003 Dec 15;146(1):65-73 [PMID: 14615068]
  24. Curr Probl Dermatol. 1995;23:1-8 [PMID: 9035901]
  25. J Invest Dermatol. 2008 Mar;128(3):717-27 [PMID: 17928891]
  26. Br J Dermatol. 1997 Aug;137(2):226-33 [PMID: 9292071]
  27. Clin Exp Dermatol. 2008 Jul;33(4):484-90 [PMID: 18462443]
  28. Toxicol Pathol. 2007 Aug;35(5):693-701 [PMID: 17763283]
  29. J Invest Dermatol. 1997 Jun;108(6):892-6 [PMID: 9182817]
  30. Toxicol Lett. 1998 Dec 28;102-103:277-82 [PMID: 10022266]
  31. Toxicol In Vitro. 2003 Jun;17(3):311-21 [PMID: 12781210]
  32. EMBO J. 2002 Jul 1;21(13):3402-13 [PMID: 12093741]

Word Cloud

Created with Highcharts 10.0.0skindermatitisHB-EGFretinolcontactICDretinoidcomparedBKCexpressionepidermalincreasedBKC-treatedtopicalchloridehairlessmice2%25%TEWLearthicknessmRNAgrowthfactorsimilarintensityEpidermalhyperplasiaprominentinvolucrinloricrinretinol-treatedElevatedRetinoidDermatitisIrritantBenzalkoniumBACKGROUND:'Retinoiddermatitis'retinoid-inducedirritantmechanismmaydifferentICDsHoweverremainsuncertaininduceOBJECTIVE:severalaspectsinducedbenzalkoniumMETHODS:appliedtransepidermalwaterlosshistologicimmunohistochemicalfindingsalsoinflammatorycytokinesdifferentialmarkerscyclooxygenasesCOXsheparinbindinglikeRESULTS:TopicalapplicationtreatedProliferatingcellnuclearantigenhigherFilaggrinhoweverexpressedIL-8TNF-alphaCOX-2filaggrinretinol-significantlyCONCLUSION:featuresBKC-inducedHyperplasiaProminentComparedContactInducedChloride

Similar Articles

Cited By